Thermoplastie bronchique : indications actuelles / Asthma thermoplasty: current indications

G. Nicolas (Toulouse, France)

Source: Virtual Congress 2021 – French programme 2021
Session: French programme 2021
Session type: Language session
Number: 59

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Nicolas (Toulouse, France). Thermoplastie bronchique : indications actuelles / Asthma thermoplasty: current indications. Virtual Congress 2021 – French programme 2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Asthma in children: an updateAsma nel bambino: un update 
Source: International Congress 2017 – ERS Italian Day programme
Year: 2017


Prise en charge de l’emphysème : Approche personnalisée / Management of emphysema: personalised approach
Source: Virtual Congress 2021 – French programme 2021
Year: 2021


Mucoviscidose: enfin des traitements ciblés / Cystic fibrosis: targeted therapies, at last !
Source: Virtual Congress 2020 – French programme 2020: Part I
Year: 2020


Place des anti-IL5 dans les pathologies éosinophiliques (hors asthme sévère) / Anti-IL-5 therapy for indications other than severe asthma
Source: Virtual Congress 2020 – French programme 2020: Part II
Year: 2020


Médecine personnalisée et BPCO: où en sommes-nous ?Personalised medicine and COPD: where are we now?
Source: International Congress 2016 – ERS/French Programme I
Year: 2016


La thermoplastie dans l’asthme : corrélation clinique et histopathologiqueAsthma thermoplasty: clinical and histopathological correlation
Source: International Congress 2017 – French Programme 2017
Year: 2017

COPD: the Italian recommendationBPCO: le raccomandazioni Italiane
Source: International Congress 2017 – ERS Italian Day programme
Year: 2017


Risques cardiovasculaires et BPCO / Cardiovascular risks and COPD
Source: Virtual Congress 2020 – French programme 2020: Part II
Year: 2020


Exacerbation aiguë de la fibrose pulmonaire idiopathique: ce qu'il ne faut plus faire et ce qu'il reste à faire. / Acute exacerbation of idiopathic pulmonary fibrosis: what should not be done and what remains to be done?
Source: Virtual Congress 2021 – French programme 2021
Year: 2021


Recommandations européennes ERS/ESC pour le diagnostic et la prise en charge de l’hypertension pulmonaireERS/ESC European guidelines for the diagnosis and treatment of pulmonary hypertension
Source: International Congress 2016 – ERS/French Programme II
Year: 2016


Surgical management of pulmonary aspergillome: about 84 cases
Source: International Congress 2019 – General thoracic surgery
Year: 2019

La diffusion pulmonaire du monoxyde d’azote (DLNO): des recommandations pratiques aux applications cliniquesLung transfer of Nitric Oxide (DLNO): from practical guidelines to clinical applications
Source: International Congress 2016 – ERS/French Programme II
Year: 2016


Troubles respiratoires du sommeil et cancer : données épidémiologiques / Respiratory disorders associated with sleep and cancer: epidemiological data
Source: Virtual Congress 2020 – French programme 2020: Part I
Year: 2020


Régulation de l'inflammation dans l'asthme : IL37 vs IL17Inflammatory regulation in asthma: IL37 vs IL17
Source: International Congress 2017 – French Programme 2017
Year: 2017

Syndrome obésité-hypoventilation: de la physiologie au traitementObesity hypoventilation: from pathophysiology to treatment
Source: International Congress 2016 – ERS/French Programme I
Year: 2016


Spanish registry of bronchiectasis: update and resultsRegistro Español de Bronquiectasias: actualización y resultados
Source: International Congress 2017 – Spanish and Portuguese Programme 2017
Year: 2017


Prise en charge de l’aspergillose pulmonaire chronique Chronic pulmonary aspergillosis care
Source: International Congress 2017 – French Programme 2017
Year: 2017


Tt anti fibrotiques hors FPI: approche raisonnée / Anti-fibrotic treatments for conditions other than idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – French programme 2020: Part I
Year: 2020